Eyantra Ventures Ltd Q4 FY26 Results

Summary

eYantra Ventures Limited announced robust top-line growth for the financial year and the fourth quarter ended March 31, 2026. The company's full-year revenue from operations surged by 144.63% to ₹67.50 crore, while Q4 revenue more than doubled to ₹13.46 crore, up 107.90% year-on-year. Although Q4 net profit witnessed a significant rise to ₹14.62 lakh, the full fiscal year saw a substantial decline in net profit by 84.05% to ₹26.53 lakh, a contrast to the strong revenue performance. The company also pursued strategic investments, including a ₹10.80 crore subscription to equity shares in NEURO AND SPINE ASSOCIATES PRIVATE LIMITED.

Key Highlights

1. 1

   eYantra Ventures Limited reported a significant increase in revenue from operations for the financial year ended March 31, 2026, reaching ₹67.50 crore, up 144.63% from ₹27.59 crore in the previous year.

2. 2

   For the fourth quarter of FY26, revenue from operations more than doubled to ₹13.46 crore, marking a 107.90% year-on-year growth compared to ₹6.47 crore in Q4 FY25.

3. 3

   Net profit for Q4 FY26 saw a substantial rise of 188.93%, climbing to ₹14.62 lakh from ₹5.06 lakh in Q4 FY25.

4. 4

   Despite strong revenue growth, the company's net profit for the full fiscal year 2026 decreased significantly by 84.05% to ₹26.53 lakh, down from ₹1.66 crore in FY25.

5. 5

   Basic Earnings Per Share for FY26 nearly doubled to ₹8.98, compared to ₹4.46 in FY25.

6. 6

   The company made a strategic investment of ₹10.80 crore by subscribing to 54,000 equity shares at ₹2,000 per share in NEURO AND SPINE ASSOCIATES PRIVATE LIMITED by March 31, 2026.

7. 7

   Additionally, eYantra Ventures allotted 1,87,500 equity shares of face value ₹10 each at a price of ₹800 each.